The role of osteoprotegerin and receptor activator of nuclear factor kappaB ligand in the pathogenesis and treatment of rheumatoid arthritis

Arthritis Rheum. 2001 Feb;44(2):253-9. doi: 10.1002/1529-0131(200102)44:2<253::AID-ANR41>3.0.CO;2-S.

Authors

L C Hofbauer¹, A E Heufelder

Affiliation

¹ Division of Gastroenterology, Endocrinology, and Metabolism, Zentrum für Innere Medizin, Philipps University, Marburg, Germany.

PMID: 11229454
DOI: 10.1002/1529-0131(200102)44:2<253::AID-ANR41>3.0.CO;2-S

No abstract available

Publication types

Research Support, Non-U.S. Gov't
Review

MeSH terms

Animals
Arthritis, Rheumatoid / etiology*
Arthritis, Rheumatoid / therapy*
Glycoproteins / physiology*
Humans
Ligands
Osteoprotegerin
Receptors, Cytoplasmic and Nuclear / physiology*
Receptors, Tumor Necrosis Factor / physiology

Substances

Glycoproteins
Ligands
Osteoprotegerin
Receptors, Cytoplasmic and Nuclear
Receptors, Tumor Necrosis Factor
TNFRSF11B protein, human